Product Information
SIROLIMUS 1 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.9516 per EA under NDC 59762100201. Its NADAC has been published 593 times since Feb 18, 2015.
Strength
1 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762100201
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SIROLIMUSApproval Type
Authorized Generic (NDA)
FDA Application
NDA021110On Market Since
10/27/2014
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 1 MG TABLET has been published 593 times since Feb 18, 2015, and over the history we have for it it has declined 92.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9516 per EA |
|---|---|
| All-time high | $13.5260 (Apr 13, 2016) |
| All-time low | $0.9516 (Jun 17, 2026) |
| 52-week high | $2.0873 |
| 52-week low | $0.9516 |
| Median price | $7.0031 |
| Average price | $6.5966 |
| Largest weekly change | -38.5% (Nov 20, 2024) |
| Weeks tracked | 593 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the SIROLIMUS market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SIROLIMUS 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 1 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.9516 per EA (NDC 59762100201), effective Jun 24, 2026.
How has the price of SIROLIMUS 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 1 MG TABLET has declined 92.4%. It has been tracked across 593 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 1 MG TABLET?
Since Feb 18, 2015, the NADAC for SIROLIMUS 1 MG TABLET has ranged from a low of $0.9516 (Jun 17, 2026) to a high of $13.5260 (Apr 13, 2016), with a median of $7.0031 per EA.
Are there cheaper alternatives to SIROLIMUS 1 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SIROLIMUS 1 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures SIROLIMUS 1 MG TABLET?
SIROLIMUS 1 MG TABLET (NDC 59762100201) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification